Publications by authors named "Junguo Lu"

Article Synopsis
  • There is a need for better second- and third-line treatments for advanced non-small-cell lung cancer (NSCLC) without driver mutations, prompting a clinical trial.
  • The trial involved 559 eligible patients with NSCLC who had failed first-line treatment and tested the effectiveness of docetaxel combined with either plinabulin or a placebo.
  • Results showed that the plinabulin group had a longer median overall survival (10.5 months) compared to the placebo group (9.4 months), with over 99% of patients experiencing treatment-related adverse events.
View Article and Find Full Text PDF
Article Synopsis
  • A study called ANEAS compared two cancer treatments, aumolertinib and gefitinib, for patients with advanced lung cancer that had spread to the brain.
  • The results showed that aumolertinib worked much better, helping patients live longer without their brain cancer getting worse compared to gefitinib.
  • Overall, more patients treated with aumolertinib responded well to the treatment, showing an improvement in their condition compared to those who received gefitinib.
View Article and Find Full Text PDF
Article Synopsis
  • Patients with non-small cell lung cancer who experienced disease progression on EGFR tyrosine kinase inhibitors (TKIs), especially third-generation ones, have limited treatment options available.* -
  • The study aimed to compare the effectiveness of ivonescimab in conjunction with chemotherapy versus chemotherapy alone for patients with relapsed advanced or metastatic non-small cell lung cancer with EGFR variants.* -
  • Results showed that the median progression-free survival was significantly higher in the ivonescimab group (7.1 months) compared to the placebo group (4.8 months), indicating a promising benefit for those receiving ivonescimab.*
View Article and Find Full Text PDF

Importance: The bioequivalence of denosumab biosimilar has yet to be studied in a 53-week, multicenter, large-scale, and head-to-head trial. A clinically effective biosimilar may help increase access to denosumab in patients with solid tumor-related bone metastases.

Objectives: To establish the biosimilarity of MW032 to denosumab in patients with solid tumor-related bone metastases based on a large-scale head-to-head study.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the safety and effectiveness of penpulimab, a PD-1 inhibitor, combined with chemotherapy for treating advanced squamous non-small-cell lung cancer (NSCLC) in patients who cannot undergo surgical resection or chemoradiotherapy.
  • - Conducted in 74 hospitals across China, this phase 3 clinical trial involved random assignment of eligible patients to receive either penpulimab plus chemotherapy or a placebo, with key assessments focusing on progression-free survival.
  • - Outcomes were analyzed based on an intention-to-treat approach, considering both the overall population and a subgroup of patients with a specific PD-L1 tumour proportion score, while ensuring masking to maintain the integrity of results.
View Article and Find Full Text PDF
Article Synopsis
  • This paper explores the stability and synchronization of fractional-order memristive neural networks that have time delays.
  • It presents new sufficient conditions for asymptotic stability using fractional-order comparison principles and inverse Laplace transforms.
  • The findings are validated through examples and indicate that the results are more applicable to a variety of situations compared to previous studies.
View Article and Find Full Text PDF
Article Synopsis
  • D-1553 (garsorasib) is an oral KRAS inhibitor being tested in a study for patients with NSCLC who have a specific KRAS mutation.
  • In the study, various dosing regimens were assessed, with most patients receiving 600 mg twice daily, revealing a manageable safety profile despite a high incidence of adverse events.
  • Results showed that D-1553 led to a 40.5% objective response rate and a disease control rate of 91.9%, suggesting it could be an effective treatment for this patient group.
View Article and Find Full Text PDF

Purpose: Aumolertinib (formerly almonertinib; HS-10296) is a novel third-generation epidermal growth factor receptor tyrosine kinase inhibitor approved in China. This double-blind phase III trial evaluated the efficacy and safety of aumolertinib compared with gefitinib as a first-line treatment for locally advanced or metastatic -mutated non-small-cell lung cancer (NSCLC; ClinicalTrials.gov identifier: NCT03849768).

View Article and Find Full Text PDF

This paper investigates the robust fault detection observer design problem in finite frequency domains for fractional-order singular systems. An H/H fault detection observer for fractional-order singular systems is designed to meet the system admissibility, disturbance robustness and fault sensitivity indices in finite frequency domains simultaneously. Four theorems and four corollaries about the system admissibility and the performance index H/H in different frequency ranges are given, and then the sufficient conditions are obtained in terms of linear matrix inequalities.

View Article and Find Full Text PDF

Background: To evaluate the efficacy and safety of recombinant human serum albumin /granulocyte colony-stimulating factor (rHSA/G-CSF) in breast cancer following receipt of cytotoxic agents.

Methods: The phase 1b trial assessed the pharmacokinetics, pharmacodynamics, and safety of dose-escalation, ranging from rHSA/G-CSF 1800 μg, 2100 μg, and 2400 μg. Randomized controlled phase 2b trial was further conducted to ensure the comparative efficacy and safety of rHSA/G-CSF 2400 μg and rhG-CSF 5 μg/kg.

View Article and Find Full Text PDF

Background: High levels of thymidylate synthase (TS) and dihydrofolate reductase (DHFR) expression in tumour tissues are an indicator of ineffective responses to pemetrexed-based chemotherapy in various tumours, including non-small cell lung cancer (NSCLC). However, tumour tissues are highly heterogeneous, so a single biopsy may not reflect genetic alterations during disease progression. This study investigated the potential use of plasma TS and DHFR mRNA levels as biomarkers for predicting sensitivity to pemetrexed-based chemotherapy.

View Article and Find Full Text PDF

This paper investigates the H control problems of singular fractional-order interval systems with commensurate order 0<α<1. Firstly, novel conditions for the bounded real lemma in the sense of H norm for nominal singular fractional-order systems are proposed, based on which the sufficient conditions for checking the admissibility and H performance of singular fractional-order interval systems are derived. Secondly, the state feedback H controller synthesis for singular fractional-order interval systems is addressed and the state feedback controller is designed.

View Article and Find Full Text PDF

In this article, the finite-time stability (FTS) of fractional-order Hopfield neural networks with time delays (FHNNTDs) is studied. A widely used inequality in investigating the stability of the fractional-order neural networks is fractional-order Gronwall inequality related to the Mittag-Leffler function, which cannot be directly used to study the stability of the factional-order neural networks with time delays. In the existing works related to fractional-order Gronwall inequality with time delays, the order was divided into two cases: λ ∈ (0,0.

View Article and Find Full Text PDF

Objectives: Fruquintinib is an orally active kinase inhibitor that selectively targets the vascular endothelial growth factor (VEGF) receptor. A Phase II trial has demonstrated a significant benefit in progression-free survival (PFS) for fruquintinib-treated patients with locally advanced/metastatic nonsquamous non-small-cell lung cancer (NSCLC) who have progressed after second-line chemotherapy. This Phase III trial is a randomized, double-blind, multicenter trial to confirm fruquintinib's efficacy in the same patient population.

View Article and Find Full Text PDF

This paper proposes a new necessary and sufficient condition for the robust stability of output feedback controlled fractional-order systems with structured uncertainties in all system coefficient matrices by using μ-analysis and the Kronecker product. The robust stability problems are converted to the judgment of the singularity of the matrices with uncertainties. Furthermore, the explicit robustness bounds of preserving the asymptotical stability of such systems are established based on the above condition.

View Article and Find Full Text PDF

Background: has been a leading healthcare-acquired infection (HAI) agent worldwide for decades. However, the epidemiological characteristics of in lung cancer patients with respiratory infection are unclear. Here, we characterized the frequency of in lung cancer patients with respiratory infection in a cancer hospital in China and determined the antibiotic resistance profile, virulence phenotype and clonal relationships among these strains.

View Article and Find Full Text PDF

Accumulating evidence reveals the essential roles of long noncoding RNAs (lncRNAs) in the non-small-cell lung cancer (NSCLC) tumorigenesis. Here, our research investigated the biological roles of novel lncRNA LINC00337 in the NSCLC tumorigenesis and discover the potential mechanism. In the NSCLC tissue and cell lines, LINC00337 was found to be remarkedly up-regulated, and the ectopic LINC00337 overexpression indicated the poor survival of NSCLC patients.

View Article and Find Full Text PDF

Circular RNAs (circRNAs) are a large class of RNAs that have previously been identified to be involved in certain diseases, including the development of cancer. However, the role of circ_001569 in non-small cell lung cancer (NSCLC) remains unknown. In the present study, it was demonstrated that expression levels of circ_001569 were significantly increased in NSCLC tissues compared with in adjacent normal tissues.

View Article and Find Full Text PDF

The current state of the art of fractional order stability theory is hardly to build connection between the time domain analysis and frequency domain synthesis. The existing tuning methodologies for fractional order PID are not always satisfy the given gain crossover frequency and phase margin simultaneously. To overcome the drawbacks in the existing synthesis of fractional order controller, the synthesis of optimal fractional order PI controller for higher-order process is proposed.

View Article and Find Full Text PDF

Nonvolatile ternary memory devices were fabricated using the composite of polystyrene (PS) and graphene oxide(GO) as active layers, which have an reliable intermediate state. The current-voltage (I-V) curves of the indium tin oxide (ITO)/PS+GO/Al device under the external applied voltages exhibited current tri-stability with three conductivity states, which clearly revealed ternary memory performance. Under the stimulus of the external voltage, a stable intermediate conductivity state was observed.

View Article and Find Full Text PDF

Memory devices based on composites of polystyrene (PS) and [6,6]-phenyl-C-butyric acid methyl ester (PCBM) were investigated with bistable resistive switching behavior. Current-voltage (I-V) curves for indium-tin-oxide (ITO)/PS + PCBM/Al devices with 33 wt% PCBM showed non-volatile, rewritable, flash memory properties with a maximum ON/OFF current ratio of 1 × 10, which was 100 times larger than the ON/OFF ratio of the device with 5 wt% PCBM. For ITO/PS + PCBM/Al devices with 33 wt% PCBM, the write-read-erase-read test cycles demonstrated the bistable devices with ON and OFF states at the same voltage.

View Article and Find Full Text PDF

Nonvolatile memory devices based on active layers of poly(vinyl alcohol) (PVA) + graphene oxide (GO) hybrid composites have been fabricated. The performance of the ITO/PVA + GO/Al device was compared with that of the ITO/PVA/Al device. The ITO/PVA + GO/Al device showed excellent performance compared to the ITO/PVA/Al device (an ON/OFF resistance ratio of 1.

View Article and Find Full Text PDF

An undoped organic small-molecule 2-(4-tert-butylphenyl)-5-(4-biphenylyl)-1,3,4-oxadiazole (PBD) and a kind of nanocomposite blending poly(methyl methacrylate) (PMMA) into PBD are employed to implement bistable resistive switching. For the bistable resistive switching indium tin oxide (ITO)/PBD/Al, its ON/OFF current ratio can touch 6. What is more, the ON/OFF current ratio, approaching to 10(4), is available due to the storage layer PBD:PMMA with the chemical composition 1:1 in the bistable resistive switching ITO/PBD:PMMA/Al.

View Article and Find Full Text PDF

This paper investigates the robust stability and stabilization of fractional order linear systems with positive real uncertainty. Firstly, sufficient conditions for the asymptotical stability of such uncertain fractional order systems are presented. Secondly, the existence conditions and design methods of the state feedback controller, static output feedback controller and observer-based controller for asymptotically stabilizing such uncertain fractional order systems are derived.

View Article and Find Full Text PDF